Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease.

Autor: Vranckx, Pascal, Leebeek, Frank W. G., Tijssen, Jan G. P., Koolen, Jacques, Stammen, Francis, Herman, Jean-Paul R., de Winter, Robbert J., van t. Hof, Arnout W. J., Backx, Bianca, Lindeboom, Wietze, So-Young Kim, Kirsch, Bodo, van Eickels, Martin, Misselwitz, Frank, Verheugt, Freek W. A.
Zdroj: Thrombosis & Haemostasis; Aug2015, Vol. 144 Issue 2, p258-267, 10p
Databáze: Complementary Index